SEC Form 4 · accession 0000898432-19-000370
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Johnson
Officer — Exec. VP of WW Sales and Mktg
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 9:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2019 | A | 1,860 | $0.93 | A | 3,228 | D | |
| Common StockF1 | Mar 5, 2019 | S | 1,860 | $25.4261 | D | 1,368 | D | |
| Common Stock | Mar 6, 2019 | A | 9,672 | $0.93 | A | 11,040 | D | |
| Common StockF2 | Mar 6, 2019 | S | 9,672 | $24.5834 | D | 1,368 | D | |
| Common Stock | Mar 7, 2019 | A | 7,614 | $0.93 | A | 8,962 | D | |
| Common StockF3 | Mar 7, 2019 | S | 7,614 | $24.5223 | D | 1,368 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $0.93 | Mar 5, 2019 | M | 1,860 | D | — | Dec 27, 2021 | Common Stock | 1,860 | 330,915 | D |
| Stock Option (Right to Buy)F5 | $0.93 | Mar 6, 2019 | M | 9,672 | D | — | Dec 27, 2021 | Common Stock | 9,672 | 321,243 | D |
| Stock Option (Right to Buy)F6 | $0.93 | Mar 7, 2019 | M | 7,614 | D | — | Dec 27, 2021 | Common Stock | 7,614 | 313,629 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $25.3 to $25.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $24.5 to $24.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $24.5 to $24.6. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
- F5This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
- F6This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.